Post by Oncidium foundation

PANTERA and Oncidium foundation are joining forces to expand access to radioligand therapy. PanTera, a Belgium-based global producer of high-purity Ac-225, has entered into a partnership with Oncidium as a corporate sponsor and through the donation of Ac-225 doses to Oncidium's #RLTConnect, a treatment donation program supporting underprivileged patients worldwide to access Radioligand Therapy. Partnerships like this bring us closer to a future where life-changing cancer care is accessible to more patients, wherever they are. We're grateful to PanTera for joining this cause and for the shared commitment that drives this collaboration forward. “𝘌𝘷𝘦𝘳𝘺 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘥𝘦𝘴𝘦𝘳𝘷𝘦𝘴 𝘵𝘩𝘦 𝘣𝘦𝘴𝘵 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘤𝘢𝘳𝘦. 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝘰𝘶𝘳 𝘱𝘢𝘳𝘵𝘯𝘦𝘳𝘴𝘩𝘪𝘱 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘖𝘯𝘤𝘪𝘥𝘪𝘶𝘮 𝘧𝘰𝘶𝘯𝘥𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘰𝘶𝘳 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘪𝘰𝘯 𝘵𝘰 𝘵𝘩𝘦 𝘙𝘓𝘛-𝘊𝘰𝘯𝘯𝘦𝘤𝘵 𝘱𝘳𝘰𝘨𝘳𝘢𝘮, 𝘗𝘢𝘯𝘛𝘦𝘳𝘢 𝘪𝘴 𝘤𝘰𝘮𝘮𝘪𝘵𝘵𝘦𝘥 𝘵𝘰 𝘮𝘢𝘬𝘪𝘯𝘨 𝘳𝘢𝘥𝘪𝘰𝘭𝘪𝘨𝘢𝘯𝘥 𝘵𝘩𝘦𝘳𝘢𝘱𝘺 𝘮𝘰𝘳𝘦 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦 𝘢𝘯𝘥 𝘪𝘮𝘱𝘢𝘤𝘵𝘧𝘶𝘭 𝘧𝘰𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘪𝘯 𝘯𝘦𝘦𝘥", said Sven Van den Berghe, CEO of PanTera. #WalkingWithOncidium #Radiotheranostics